These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27983948)

  • 1. Probing the orientation of inhibitor and epoxy-eicosatrienoic acid binding in the active site of soluble epoxide hydrolase.
    Lee KS; Henriksen NM; Ng CJ; Yang J; Jia W; Morisseau C; Andaya A; Gilson MK; Hammock BD
    Arch Biochem Biophys; 2017 Jan; 613():1-11. PubMed ID: 27983948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase.
    Widstrom RL; Norris AW; Van Der Veer J; Spector AA
    Biochemistry; 2003 Oct; 42(40):11762-7. PubMed ID: 14529287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Protein Sci; 2006 Jan; 15(1):58-64. PubMed ID: 16322563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
    Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of soluble epoxide hydrolase (sEH) activity.
    Morisseau C; Hammock BD
    Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.23. PubMed ID: 23045145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis.
    Zeldin DC; Wei S; Falck JR; Hammock BD; Snapper JR; Capdevila JH
    Arch Biochem Biophys; 1995 Jan; 316(1):443-51. PubMed ID: 7840649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Biochemistry; 2004 Apr; 43(16):4716-23. PubMed ID: 15096040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
    Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
    Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase: gene structure, expression and deletion.
    Harris TR; Hammock BD
    Gene; 2013 Sep; 526(2):61-74. PubMed ID: 23701967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of soluble epoxide hydrolase. Formation of an alpha-hydroxy ester-enzyme intermediate through Asp-333.
    Borhan B; Jones AD; Pinot F; Grant DF; Kurth MJ; Hammock BD
    J Biol Chem; 1995 Nov; 270(45):26923-30. PubMed ID: 7592938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.
    Pallàs M; Vázquez S; Sanfeliu C; Galdeano C; Griñán-Ferré C
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32369955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
    Revermann M
    Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide.
    Rand AA; Helmer PO; Inceoglu B; Hammock BD; Morisseau C
    Methods Mol Biol; 2018; 1730():123-133. PubMed ID: 29363071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of epoxy fatty acids and related compounds to cells expressing human soluble epoxide hydrolase.
    Greene JF; Newman JW; Williamson KC; Hammock BD
    Chem Res Toxicol; 2000 Apr; 13(4):217-26. PubMed ID: 10775319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues.
    Morisseau C; Kodani SD; Kamita SG; Yang J; Lee KSS; Hammock BD
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
    Frömel T; Hu J; Fleming I
    Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
    Huang H; Weng J; Wang MH
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth.
    Oguro A; Sakamoto K; Suzuki S; Imaoka S
    Biol Pharm Bull; 2009 Dec; 32(12):1962-7. PubMed ID: 19952412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.